| Influence of medications and diagnoses on fall risk in psychiatric inpatients. | |
| | |
MedLine Citation:
|
PMID: 20651318 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
PURPOSE: The influence of medications and diagnoses on fall risk in psychiatric inpatients was evaluated. METHODS: In this retrospective case-control study, psychiatric inpatients age 18 years or older with a documented fall that was reported served as study cases. These patients were matched to control patients from the same hospital (1:1) by admission year, sex, and age. Psychiatric diagnoses evaluated included major depressive disorder, schizophrenia or schizoaffective disorder, bipolar disorder, Alzheimer's disease and dementia, anxiety or neurosis, delirium, personality disorder, and obsessive-compulsive disorder. Medications assessed as independent variables were conventional antipsychotics, atypical antipsychotics, selective serotonin-reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, monoamine oxidase inhibitors, lithium, anticonvulsants, benzodiazepines, nonbenzodiazepine sleep aids, Alzheimer's disease medications, antihistamines, antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H(2)-receptor blockers, laxatives and stool softeners, muscle relaxants, nonsteroidal antiinflammatory drugs, opioids, Parkinson's disease medications, and overactive bladder medications. Univariate logistic regression models were developed for each risk factor to determine its impact on fall risk. RESULTS: A total of 774 patient cases were matched with controls. Most falls occurred on the second day of hospitalization. Medications associated with a higher risk of falls were alpha-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H(2)-blockers, lithium, antipsychotics, atypical antidepressants, anticonvulsants, and laxatives and stool softeners. Patients with a diagnosis of dementia and Alzheimer's disease also had an increased risk of falling. CONCLUSION: Alpha-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H(2)-blockers, lithium, atypical antipsychotics, atypical antidepressants, anticonvulsants and mood stabilizers, conventional anti-psychotics, laxatives and stool softeners, and dementia and Alzheimer's disease were significant predictors of inpatient falls in a psychiatric population. |
| | |
Authors:
|
Stacey M Lavsa; Tanya J Fabian; Melissa I Saul; Shelby L Corman; Kim C Coley |
Related Documents
:
|
12494838 - Medication management for people with a diagnosis of schizophrenia. 11481688 - Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic pa... 15352538 - New options in the pharmacological management of attention-deficit/hyperactivity disorder. 3624218 - Legal liability with psychotropic drug use: extrapyramidal syndromes and tardive dyskin... 16498478 - Career choices of new zealand junior doctors. 14768768 - Promoting adherence: effects of theory-based asthma education. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists Volume: 67 ISSN: 1535-2900 ISO Abbreviation: Am J Health Syst Pharm Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503023 Medline TA: Am J Health Syst Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 1274-80 Citation Subset: IM |
Affiliation:
|
University Medical Center, University of Pittsburgh, 3501 Terrace Street, Pittsburgh, PA 15261, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and pre...
Next Document: Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritis.